Literature DB >> 25121499

NICE supports allowing technology assessment bodies to provide advice to drug industry.

Carole Longson1, Nick Crabb2, Leeza Osipenko2.   

Abstract

Mesh：

Year:  2014        PMID： 25121499     DOI： 10.1136/bmj.g5035

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  1 in total

1.  Integrating health technology assessment requirements in the clinical development of medicines: the experience from NICE scientific advice.

Authors:  François Maignen; Leeza Osipenko; Pilar Pinilla-Dominguez; Emily Crowe
Journal:  Eur J Clin Pharmacol       Date:  2016-12-10       Impact factor: 2.953
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.